Literature DB >> 19682525

Regional brain metabolism with cytochrome c oxidase histochemistry in a PS1/A246E mouse model of autosomal dominant Alzheimer's disease: correlations with behavior and oxidative stress.

Catherine Strazielle1, Rozat Jazi, Yann Verdier, Sue Qian, Robert Lalonde.   

Abstract

Mitochondrial dysfunction and brain metabolic alteration are early neurofunctional aspects in Alzheimer's disease (AD). Regional brain metabolism was analyzed by cytochrome c oxidase (COX) histochemistry in PS1-A246E mouse mutants, a model of autosomal dominant AD overexpressing beta-amyloid (Abeta) peptide without amyloidosis or cell degeneration. Immunohistochemical samples were analyzed on adjacent sections for regional Abeta1-42 levels, as well as DNA oxidative damage with 8-hydroxy-2-deoxyguanosine (8-OHdG). COX activity increased in the basal forebrain nuclear complex, specific parts of the amygdala and hippocampus, as well as in striatum and connected regions. On the contrary, a hypometabolism was observed in midline thalamic, interpeduncular, and pedonculopontine nuclei. The integration of these regions in circuitries subserving emotions, arousal, and cognitive functions may explain why neurochemical alterations in specific brain regions were linearly correlated with psychomotor slowing and disinhibition previously reported in the mutant. As the PS1-A246E model appears to mimick prodromal AD, the results support the existence of mitochondrial abnormalities prior to AD-related cognitive deficits. However, since affected PS1-A246E brain regions were not primarily those altered in AD-associated histopathological features and did not systematically display either Abeta overexpression or higher 8-OHdG immunolabelling, the hypermetabolism observed seems to comprise a compensatory reaction to early mitochondrial abnormalities; furthermore, neuronal synaptic function should be considered as particularly relevant in COX activity changes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682525     DOI: 10.1016/j.neuint.2009.08.005

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  13 in total

1.  Genetic association of SLC2A14 polymorphism with Alzheimer's disease in a Han Chinese population.

Authors:  Wei Wang; Jin-Tai Yu; Wei Zhang; Wei-Zhen Cui; Zhong-Chen Wu; Qun Zhang; Lan Tan
Journal:  J Mol Neurosci       Date:  2012-03-16       Impact factor: 3.444

2.  Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?

Authors:  Liang-Jun Yan; Ming Xiao; Ran Chen; Zhiyou Cai
Journal:  Aging Neurodegener       Date:  2013-08

Review 3.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

4.  Increased phosphorylation of tau and synaptic protein loss in the aged transgenic mice expressing familiar Alzheimer's disease-linked presenilin 1 mutation.

Authors:  Xifei Yang; Ying Yang; Jianjun Liu; Geng Li; Edward Yang
Journal:  Neurochem Res       Date:  2011-08-13       Impact factor: 3.996

5.  Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease.

Authors:  Pollyana Feldhaus; Daiane B Fraga; Fernando V Ghedim; Renata D De Luca; Thiago D Bruna; Matheus Heluany; Maria Paula Matos; Gabriela K Ferreira; Isabela C Jeremias; Claudia Heluany; Emilio L Streck; Alexandra I Zugno
Journal:  Metab Brain Dis       Date:  2011-07-26       Impact factor: 3.584

6.  Sodium Channel Voltage-Gated Beta 2 Plays a Vital Role in Brain Aging Associated with Synaptic Plasticity and Expression of COX5A and FGF-2.

Authors:  Yan-Bin XiYang; You-Cui Wang; Ya Zhao; Jin Ru; Bing-Tuan Lu; Yue-Ning Zhang; Nai-Chao Wang; Wei-Yan Hu; Jia Liu; Jin-Wei Yang; Zhao-Jun Wang; Chun-Guang Hao; Zhong-Tang Feng; Zhi-Cheng Xiao; Wei Dong; Xiong-Zhi Quan; Lian-Feng Zhang; Ting-Hua Wang
Journal:  Mol Neurobiol       Date:  2015-01-10       Impact factor: 5.590

7.  Cortical metabolic deficits in a rat model of cholinergic basal forebrain degeneration.

Authors:  Francesca Gelfo; Laura Petrosini; Alessandro Graziano; Paola De Bartolo; Lorena Burello; Emilia Vitale; Arianna Polverino; Antonietta Iuliano; Giuseppe Sorrentino; Laura Mandolesi
Journal:  Neurochem Res       Date:  2013-08-08       Impact factor: 3.996

Review 8.  Modeling mitochondrial dysfunctions in the brain: from mice to men.

Authors:  Megan E Breuer; Peter H G M Willems; Frans G M Russel; Werner J H Koopman; Jan A M Smeitink
Journal:  J Inherit Metab Dis       Date:  2011-07-14       Impact factor: 4.982

9.  Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals.

Authors:  M Bomba; D Ciavardelli; E Silvestri; L M T Canzoniero; R Lattanzio; P Chiappini; M Piantelli; C Di Ilio; A Consoli; S L Sensi
Journal:  Cell Death Dis       Date:  2013-05-02       Impact factor: 8.469

Review 10.  Deconstructing mitochondrial dysfunction in Alzheimer disease.

Authors:  Vega García-Escudero; Patricia Martín-Maestro; George Perry; Jesús Avila
Journal:  Oxid Med Cell Longev       Date:  2013-06-11       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.